Top Markets
Coin of the day
Novartis AG Novartis AG

Novartis AG

NVS
Ранг среди акций #47
Novartis AG researches, develops, manufactures, and markets healthcare products... Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Цена акции
$150.75
Рыночная капитализация
$291.41B
Изменение (1 день)
1.44%
Изменение (1 год)
40.17%
Страна
CH
Торговля Novartis AG (NVS)

Категория

Коэффициент P/B для Novartis AG (NVS)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Novartis AG, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Novartis AG с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
33.3372 -
US
6.0657 -
GB
7.1931 -
US
-119.6075 -
US
5.4725 -
US